CSIRO's research is focused on the following:
Australian Animal Health Laboratory - AAHL plays a key role in protecting public health, animal health, community resilience and trade. Learn more>
Australian Biotech Growth Partnerships - Supports the growth of the biotechnology industry, providing access to CSIRO's capabilities and infrastructure. Learn more>
The Australian e-Health Research Centre - A partnership between CSIRO and the Queensland Government, dedicated to improving health services and clinical treatment for Australians. Learn more>
Bio21 Collaborative Crystallisation Centre - Bio21-C3 provides the infrastructure capability to advance biotechnology and medical
research. Learn more>
Analysis at Point of Sampling (APOS) - A hand-held sensor systems for detection and analysis of biochemical and biological materials. Learn more>
Carbon Nanotube Yarn - CSIRO is developing ways to use carbon nanotube components in biomedical devices. Learn more>
Electrospinning creates ultra-fine fibres - Experimental textiles produced by electrospinning are being assessed for medical, industrial and environmental applications. Learn more>
Fluid Dynamics - CSIRO’s biofluid dynamics team develops original medical device technologies to support industries involved in medical devices, diagnostics and treatment. Learn more>
RAFT technologies - CSIRO and DuPont have developed Reversible Addition-Fragmentation chain Transfer (RAFT) for the synthesis of highly specific small‑molecule and biological therapeutics. Learn more>
Working closely with industry partners, CSIRO collaborates on product and technology developments for health and medical related outcomes.
CSIRO draws upon the expertise of chemists, biologists, physicists, engineers and material scientists to address key challenges in health. Our focus is on developing new ‘smart’ technologies which offer platform opportunities where specific parts of the technology can be adapted to many end uses in health and medicine.
 | This one day symposium will bring together international and national experts to provide a comprehensive, up-to-date overview of the field of nutrition and genetics that determine the quality of growth and development from conception and throughout early life. |
 | The Preventative Health Flagship is working to improve the health and wellbeing of Australians through research into prevention and early detection of common chronic diseases. |
 | A renowned researcher into the development of technologies designed to prevent blindness, Dr Kanagasingam Yogesan, has been appointed Research Director of the Australian e-Health Research Centre (AEHRC). |
 | CSIRO is using the latest in computer gaming technology to help reduce the incidence of one of the most common cancers in Australia – bowel cancer. |
 | This Symposium is a satellite meeting of OzBio 2010 and is sponsored by CSIRO and the Australian Society for Biochemistry and Molecular Biology. |
 | This free two-day workshop/symposium will bring together international and national experts to provide a comprehensive, up-to-date overview of Quantitative Imaging Cytometry. |
 | The Diagnosis, Surveillance and Response Group delivers CSIRO's national responsibilities in the area of emergency terrestrial animal and fish diseases, including diseases of wildlife and zoonotic diseases. |
 | CSIRO's Diagnosis, Surveillance and Response Group provides a comprehensive diagnostic service for emergency animal diseases, routine quarantine testing, technical advice, education and training. |
 | Our Molecular and Cell Biology capability employs expertise in antibody engineering, the molecular and cellular biology of biomaterials, matrix biology, protein and scaffold display technology, growth factor receptor biology and molecular evolution. |
 | CSIRO’s large, integrated team of professional scientists and engineers research the new physics of the nanoscale. They cover biomimetics, nanoparticle films, biosensor arrays and molecular electronics. |
 | A video showing an interview of the Kolling Institute's Kerrie MacDonald, as she speaks about how the Kolling Institute and CSIRO have discovered genes that differentiate between different types of brain tumours. (0:49) |
 | A CSIRO team - led by Dr Linfa Wang - has played a key role in uncovering a new reovirus that can cause a respiratory tract illness in humans. In this video, Dr Wang explains the significance of the discovery to CSIRO Communication Advisor, Ms Emma Wilkins. (6:00) |
 | Dr Martyn Jeggo leads the Australian Animal Health Laboratory (AAHL), which is a global leader in research and diagnosis of major diseases affecting livestock throughout the world, including new and emerging diseases. |
 | Dr Susie Nilsson’s work focuses on understanding the adult haemopoietic stem cell niche to improve bone marrow transplantation outcomes. |
 | Registration form for the 2nd Nutritional Genomics Symposium, 30 July 2010, Adelaide, South Australia. (1 page) |
 | Information for individuals who wish to submit abstracts for the 2nd Nutritional Genomics Symposium, July 30 2010, Adelaide, South Australia. (1 page) |
 | An overview of CSIRO's Structure based drug design research including services, expertise, collaboration and facilities. (1 page) |
 | CSIRO can provide assistance with optimisation, scale-up, production and purification of recombinant proteins in large quantities: from hundreds of milligrams to kilograms. (2 pages) |
|
|
New to
Health Technologies
|